DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients. [electronic resource]
Producer: 20190903Description: e16813 p. digitalISSN:- 1536-5964
- Adult
- Anti-HIV Agents -- administration & dosage
- CD4 Lymphocyte Count
- Cost-Benefit Analysis
- Drug Therapy, Combination
- Economics, Pharmaceutical
- Fees, Pharmaceutical -- statistics & numerical data
- Female
- HIV Infections -- drug therapy
- HIV-1
- Heterocyclic Compounds, 3-Ring -- administration & dosage
- Humans
- Lamivudine -- administration & dosage
- Male
- Middle Aged
- Oxazines
- Piperazines
- Pyridones
- Retrospective Studies
- Viral Load
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.